Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase 3 trial of S-1 vs gemcitabine in untreated advanced pancreatic cancer
jRCT2080221441Phase 3Completed
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in pancreatic cancer (PC) comparing S-1 with Gemcitabine (2 arms). Started Apr 2011; status: completed.
02
Drugs
tegafurgemcitabine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on jRCT2080221441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221441.